# Childhood-onset ocular mucous membrane pemphigoid presenting with peripheral ulcerative keratitis: a case report and review of the literature

**Authors:** Eugenia M. Ramos-Dávila, Raul E. Ruiz-Lozano, Alejandro Rodríguez-García, Carlos Álvarez-Guzmán

PMC · DOI: 10.1186/s12348-025-00480-y · Journal of Ophthalmic Inflammation and Infection · 2025-05-29

## TL;DR

A 12-year-old girl with rare ocular mucous membrane pemphigoid showed successful treatment with methotrexate after initial therapies failed.

## Contribution

This is the first reported case of pediatric ocular MMP in a Hispanic patient presenting with peripheral ulcerative keratitis and responding to methotrexate.

## Key findings

- The patient's diagnosis was confirmed via conjunctival biopsy and immunofluorescence showing basement membrane zone deposits.
- Methotrexate successfully controlled disease activity after initial treatments with dapsone and prednisone failed.
- After three years of follow-up, the patient remained free of disease activity.

## Abstract

The purpose of this study was to describe the case of a pediatric patient diagnosed with mucous membrane pemphigoid (MMP) with exclusive ocular involvement presenting at diagnosis with peripheral ulcerative keratitis and provide a review of the literature.

A 12-year-old girl presented with cicatricial conjunctivitis and peripheral ulcerative keratitis (PUK). A conjunctival biopsy and direct immunofluorescence revealed linear deposits of IgG, IgM, and C3 at the basement membrane zone, confirming a diagnosis of ocular MMP.

The patient was initially treated with dapsone 25 mg/day and prednisone 40 mg/day along with topical treatment including cyclosporine 0.05%, loteprednol etabonate 0.05%, and sodium hyaluronate 0.15% and trehalose 3%. Inflammation persisted as an increase in the extension of symblepharon was documented. Subsequently, dapsone was switched to oral methotrexate 15 mg/week and prednisone was successfully tapered to 5 mg/day. After three years of follow-up, disease activity remained quiescent.

Pediatric mucous membrane pemphigoid with ocular involvement is a rare condition of which few reports have been published, resulting in scarce information regarding its clinical course and response to treatment. We report the first case observed in a Hispanic patient, opening with peripheral ulcerative keratitis, and responding successfully to methotrexate.

## Linked entities

- **Chemicals:** dapsone (PubChem CID 2955), prednisone (PubChem CID 5865), cyclosporine (PubChem CID 5284373), loteprednol etabonate (PubChem CID 444025), trehalose (PubChem CID 7427), methotrexate (PubChem CID 4112)
- **Diseases:** mucous membrane pemphigoid (MONDO:0018746)

## Full-text entities

- **Diseases:** MMP (MESH:D010390), Inflammation (MESH:D007249), conjunctivitis (MESH:D003231), PUK (MESH:D003320)
- **Chemicals:** dapsone (MESH:D003622), methotrexate (MESH:D008727)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12123039/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12123039/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12123039/full.md

---
Source: https://tomesphere.com/paper/PMC12123039